Comprehensive assessment of the morbidity of renal mass biopsy: A population-based assessment of biopsy-related complications.

CONCLUSIONS: Patients undergoing RMB may have a small but non-negligible increased risk of mortality, hospital readmission, and ED visits compared to matched controls. However, limitations in the granularity of the dataset limits the strength of these conclusions. Further studies are needed to confirm our results. These risks should be discussed with patients for shared decision-making and considered in the risk/benefit tradeoff for the management of small renal masses.
PMID: 32744997 [PubMed - as supplied by publisher]

Source: Canadian Urological Association Journal - July 26, 2020 Category: Urology & Nephrology Authors: Garbens A, Wallis CJD, Klaassen Z, Saskin R, Plumptre L, Kodama R, Herschorn S, Nam RK Tags: Can Urol Assoc J Source Type: research